Mergers & Acquisitions ·
Albemarle Corporation is divesting portions of its Ketjen business through a stock sale and the Eurecat S.A.…
ALBAlbemarle Corp
Albemarle Corporation is divesting portions of its Ketjen business through a stock sale and the Eurecat S.A. divestiture, which is expected to generate approximately $660 million in total cash proceeds for debt reduction and corporate purposes. In connection with these transactions, the company expects to record a $181.5 million non-cash goodwill impairment charge in the third quarter of 2025. This strategic realignment aims to strengthen the company's balance sheet and streamline its operational portfolio.